Next Article in Journal
Structure and Formation Mechanism of Antimicrobial Peptides Temporin B- and L-Induced Tubular Membrane Protrusion
Next Article in Special Issue
The Trace Element Selenium Is Important for Redox Signaling in Phorbol Ester-Differentiated THP-1 Macrophages
Previous Article in Journal
m6A Modified Short RNA Fragments Inhibit Cytoplasmic TLS/FUS Aggregation Induced by Hyperosmotic Stress
Previous Article in Special Issue
Initial Step of Selenite Reduction via Thioredoxin for Bacterial Selenoprotein Biosynthesis
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
IJMS
Volume 22
Issue 20
10.3390/ijms222011010
ijms-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Female Mice with Selenocysteine tRNA Deletion in Agrp Neurons Maintain Leptin Sensitivity and Resist Weight Gain While on a High-Fat Diet

by
Daniel J. Torres
1,2,*,
Matthew W. Pitts
2,
Lucia A. Seale
1,
Ann C. Hashimoto
2,
Katlyn J. An
2,
Ashley N. Hanato
2,
Katherine W. Hui
2,
Stella Maris A. Remigio
2,
Bradley A. Carlson
3,
Dolph L. Hatfield
3 and
Marla J. Berry
1
1
Pacific Biosciences Research Center, School of Ocean and Earth Science and Technology, University of Hawaii at Manoa, Honolulu, HI 96822, USA
2
Department of Cell and Molecular Biology, John A. Burns School of Medicine, University of Hawaii at Manoa, Honolulu, HI 96813, USA
3
Molecular Biology of Selenium Section, Mouse Cancer Genetics Program, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2021, 22(20), 11010; https://doi.org/10.3390/ijms222011010
Submission received: 16 September 2021 / Revised: 4 October 2021 / Accepted: 7 October 2021 / Published: 12 October 2021
(This article belongs to the Special Issue Molecular Biology of Selenium in Health and Disease)
Browse Figures
Versions Notes

Abstract

:
The role of the essential trace element selenium in hypothalamic physiology has begun to come to light over recent years. Selenium is used to synthesize a family of proteins participating in redox reactions called selenoproteins, which contain a selenocysteine residue in place of a cysteine. Past studies have shown that disrupted selenoprotein expression in the hypothalamus can adversely impact energy homeostasis. There is also evidence that selenium supports leptin signaling in the hypothalamus by maintaining proper redox balance. In this study, we generated mice with conditional knockout of the selenocysteine tRNA[Ser]Sec gene (Trsp) in an orexigenic cell population called agouti-related peptide (Agrp)-positive neurons. We found that female TrspAgrpKO mice gain less weight while on a high-fat diet, which occurs due to changes in adipose tissue activity. Female TrspAgrpKO mice also retained hypothalamic sensitivity to leptin administration. Male mice were unaffected, however, highlighting the sexually dimorphic influence of selenium on neurobiology and energy homeostasis. These findings provide novel insight into the role of selenoproteins within a small yet heavily influential population of hypothalamic neurons.

1. Introduction

As the global obesity pandemic worsens [1], gaining a better understanding of the molecular mechanisms involved is necessary for developing effective treatments. The hypothalamus of the brain, which regulates energy homeostasis throughout the body, becomes impaired in the obese state and is a potential therapeutic target [2]. In recent years, the role of the essential trace element selenium in supporting hypothalamic function, particularly in response to a high-fat diet (HFD), has begun to come to light [3]. Selenium is used to synthesize selenoproteins, a family of proteins that promote redox balance and support physiological processes such as thyroid hormone metabolism [4] and the inflammatory response [5]. Within the hypothalamus, multiple selenoproteins exhibit high levels of expression that appear to be influenced by changes in nutritional status [6,7]. Mouse models with genetic manipulation of selenoprotein expression targeting the hypothalamus have exhibited significant metabolic repercussions [8,9,10].
Previously, Yagishita et al. [8] demonstrated that broad hypothalamic deletion of the selenocysteine tRNA[Ser]Sec gene (Trsp), which is required for selenoprotein biosynthesis, increases the susceptibility to diet-induced obesity (DIO) in mice. Knockout of Trsp in rat-insulin-promoter (RIP)-positive cells induced oxidative stress and resistance to insulin and leptin, highlighting the critical nature of hypothalamus-resident selenoproteins in energy homeostasis. Conditional Trsp knockout was noted to affect a wide range of neuronal cell types, including anorexigenic pro-opiomelanocortin (Pomc) neurons and astrocytes [8]. Among the cell types not affected were the appetite-stimulating agouti-related peptide (Agrp)-positive neurons, a group of ‘first order’ neurons contained within the arcuate nucleus (Arc) of the hypothalamus that is capable of detecting circulating nutrients and hormones such as leptin. This small neuronal subpopulation releases the inhibitory neurotransmitter γ-Aminobutyric acid (GABA) as well as the neuropeptides Agrp and Neuropeptide y (Npy) to suppress the release of thyrotropin-releasing hormone (TRH) and corticotropin-releasing hormone (CRH), which signal to the pituitary gland to promote energy expenditure from the paraventricular nucleus of the hypothalamus. Due to their unique location at the interface between the brain and the bloodstream and their pronounced influence on energy homeostasis, Agrp neurons have increasingly garnered attention as a potential therapeutic target in treating metabolic disease. To assess the role of selenoproteins in Agrp neurons, we created mice with Agrp-Cre-driven knockout of Trsp. We report that the loss of Trsp from Agrp neurons conferred protection from DIO in a sex-dependent manner.

2. Results

2.1. In Vivo Metabolic Assessment of Mice with Agrp Neuron-specific Ablation of Trsp

To generate mice with Agrp neurons lacking selenoprotein biosynthesis, we crossed Trsp-floxed mice with Agrp-Cre mice, resulting in mice with a deletion of the Trsp gene in Agrp neurons, referred to as TrspAgrpKO mice. Control mice consisted of age-matched Agrp-Cre mice. Both groups were fed an HFD beginning at 4 weeks of age, after which we monitored body weight and performed metabolic phenotyping. Female TrspAgrpKO mice displayed resistance to DIO, gaining roughly 20% less weight than controls by 14 weeks of age (Figure 1a). Weight gained by male TrspAgrpKO mice, on the other hand, did not differ from controls (Figure 1b). Female TrspAgrpKO mice also displayed reduced adiposity (Figure 1c) and improved glucose tolerance (Figure 1d,e). Consistent with overall body weight trends, male TrspAgrpKO mice exhibited similar levels of adiposity (Figure 1c) and glucose sensitivity (Figure 1f) in comparison to control mice.
The primary mechanism through which Agrp neurons control energy homeostasis is the promotion of feeding behavior [11]. Thus, we used specialized metabolic chambers (OxyletPro Physiocage System, Harvard Apparatus) that allow for constant monitoring of single-housed subjects to measure food intake, physical activity, and respiratory metabolism. Although female TrspAgrpKO mice were underweight, no significant difference in total food intake was detected compared to controls in either the light or dark phase (Figure 1g,h). Meal analysis revealed a significantly larger inter-meal interval in female TrspAgrpKO mice during the light phase (Supplementary Figure S1a), but no changes were observed in any of the other metrics analyzed, which included meal size, meal duration, meal count, and eating rate (data not shown). There were also no detectable changes in physical activity in female TrspAgrpKO mice in terms of either total locomotion (Supplementary Figure S1b,c) or rearing events (Supplementary Figure S1d).
Since neither feeding behavior nor physical activity seemed to be able to account for resistance to DIO observed in female TrspAgrpKO mice, we also probed for changes in respiratory metabolism using the metabolic chamber system. Female TrspAgrpKO mice displayed increased rates of oxygen consumption (Figure 2a,b) and carbon dioxide production (Figure 2c,d) compared to control Agrp-Cre mice. These differences persisted throughout the duration of both the light and dark cycles. Energy expenditure was estimated using indirect calorimetry and was found to be significantly elevated in female TrspAgrpKO mice (Figure 2e,f). Male TrspAgrpKO mice did not display any significant changes in respiratory metabolism (Supplementary Figure S1e,f).

2.2. Measurement of Hormones in Serum from TrspAgrpKO Mice

Despite having reduced adiposity, female TrspAgrpKO mice did not present altered levels of circulating leptin, while insulin levels trended downward (Table 1). Agrp neurons affect the peripheral energy metabolism processes by indirectly suppressing the activity of the pituitary gland. There were no significant differences in serum levels of pituitary hormones between TrspAgrpKO and control females. There was a downward trend in follicle-stimulating hormone (FSH) that nearly reached statistical significance, however. Male TrspAgrpKO mice had reduced circulating levels of growth hormone (GH), while all other measured hormones were not affected (Table 1).

2.3. Histological Analysis of TrspAgrpKO Mouse Brown Adipose Tissue

In addition to regulating appetite, Agrp neurons are able to influence other metabolic processes, including the thermogenic activity of interscapular brown adipose tissue (BAT) [11]. To evaluate the potential influence of Agrp neuron-specific Trsp ablation on BAT thermogenesis, we performed histological analysis of BAT morphology. Lipid droplet size was significantly decreased in BAT sections from female TrspAgrpKO mouse BAT, while male TrspAgrpKO mice were unaffected (Figure 3a–c). Lipid deposits also occupied a smaller fraction of BAT section surface area on average in female TrspAgrpKO mice (Figure 3d). Expression of uncoupling protein-1 (UCP1), a marker of thermogenesis, was not significantly changed in TrspAgrpKO mouse BAT sections (Supplementary Figure S2a,b).

2.4. Assessment of Leptin Sensitivity in the Hypothalamus of TrspAgrpKO Mice

To investigate the neural mechanism underlying the DIO resistance phenotype of female TrspAgrpKO mice, we performed post-mortem tissue analysis. In response to HFD, the rodent hypothalamus typically develops leptin resistance due to inflammation and oxidative stress [12]. Accumulating evidence suggests that selenoproteins play a major role in regulating hypothalamic leptin signaling [3,13,14]. Therefore, we challenged the mice with intraperitoneal leptin injection prior to sacrifice. Western blot analysis of the whole hypothalamus revealed that female TrspAgrpKO mice maintained leptin sensitivity, demonstrated by a significant increase in expression of the leptin signaling protein signal transducer and activator of transcription 3 (STAT3) in response to leptin administration (Figure 4a,b), while control mice developed leptin resistance. As expected, male control and TrspAgrpKO mice developed leptin resistance in response to HFD (Figure 4c,d).
Immunohistochemical measurement of STAT3 expression in hypothalamic sections confirmed that the Arc of the hypothalamus, where Agrp neurons reside, maintains leptin sensitivity in female TrspAgrpKO mice (Figure 5a,b). The number of STAT3-positive cells did not increase in response to leptin, however, suggesting a more robust response within a comparable population of leptin-receptor-expressing neurons within the Arc (Figure 5c). Hypothalamic sections from male TrspAgrpKO mice showed no significant response to leptin (Figure 5d,e). Importantly, the number of STAT3-positive cells in TrspAgrpKO males was comparable to the number present in control mouse sections (Figure 5f).

2.5. Analysis of Neuropeptide Expression in the TrspAgrpKO Mouse Hypothalamus

No significant changes in the protein expression of Agrp were observed as a result of Trsp deletion in Agrp neurons of female mice (Figure 6a–c). Interestingly, Pomc was upregulated in the hypothalamus of female TrspAgrpKO mice in response to leptin (Figure 6c). Male TrspAgrpKO mice did not display any significant changes in the levels of hypothalamic neuropeptides (Figure 6d–f).

3. Discussion

We report here that the ablation of selenoprotein synthesis via Trsp deletion in the Agrp neurons of mice results in a phenotype that is protected against DIO and leptin resistance. This protection was only observed in female mice, however, as male TrspAgrpKO mice gained as much weight and adiposity as controls while on an HFD and developed leptin resistance. Female TrspAgrpKO mice gained approximately 20% less weight on average than control Agrp-Cre mice while on an HFD. Inguinal white adipose tissue (WAT) deposits were about 40% smaller than that found in controls, indicating a leaner body composition, which was accompanied by slightly better glucose sensitivity. Despite the fact that Agrp neurons heavily influence food-seeking behavior, we found that female TrspAgrpKO mice consumed similar amounts of food as their control counterparts. The amount of time that elapsed between meals was significantly larger in female TrspAgrpKO mice during the light phase, but no other metrics of meal consumption, such as meal size or meal count, were changed. Thus, although there appears to be some modification of feeding behavior, it is unclear whether an increased inter-meal interval in the light phase could account for the 20% decrease in weight gain observed in female TrspAgrpKO mice.
It is worth noting that female TrspAgrpKO mice were undersized compared to their Agrp-Cre counterparts at as early as 4 weeks of age, just prior to HFD exposure (Supplementary Figure S2c). Although these data suggest a developmental growth deficit in female mice due to Trsp deletion in Agrp neurons, it is unlikely that it can explain the difference in body weight in adulthood following HFD administration, considering the striking differences in adiposity. Moreover, body lengths measured at 24 weeks of age were not significantly different between groups (Supplementary Figure S2d). A major limitation of the current study is that it did not include an experiment with mice on a control diet. Further investigation that includes a control diet will provide additional insight on this and other aspects of the lean phenotype of female TrspAgrpKO mice.
Energy expenditure was found to be significantly elevated in female TrspAgrpKO mice. This finding could not be accounted for by a change in physical activity, which remained unchanged, however, suggesting the upregulation of an energy-consuming process within female TrspAgrpKO mice. Increased BAT thermogenesis is a potential candidate as lipid depositions were reduced in female TrspAgrpKO mice BAT and the influence of Agrp neural activity on thermogenesis is well established [11]. This is consistent with our previous findings in mice with Agrp neurons lacking the selenium recycling enzyme selenocysteine lyase (Scly), SclyAgrpKO mice, which displayed smaller BAT lipid droplets and increased UCP1 expression in the BAT. We did not observe a change in UCP1 expression in the BAT of TrspAgrpKO mice, however, which may suggest a UCP1-independent thermogenic process such as BAT Ca2+ cycling thermogenesis or WAT lipolysis [15]. Interestingly, recent studies have depicted the ability of the hypothalamus to increase energy expenditure via sympathetic tone to WAT without affecting BAT UCP1 expression [16].
We did not detect any significant changes in pituitary gland hormones in female TrspAgrpKO mice that can explain their resistance to DIO. Circulating levels of FSH, which plays a role in limiting thermogenesis and WAT browning in mice [17], trended downwards in female TrspAgrpKO mice, although the change was not quite statistically significant (p = 0.05). Interestingly, blocking FSH activates BAT and reduces adiposity in female mice [17]. Since the thyroid-stimulating hormone (TSH) was unchanged, Agrp neurons lacking Trsp may be promoting a lean phenotype through a pathway that involves sympathetic innervation rather than endocrine means. In addition to synapsing on the neurosecretory neurons of the paraventricular nucleus, Agrp neurons project to multiple other regions within the hypothalamus. One of these regions, the dorsomedial hypothalamus (DMH), is known to regulate thermogenesis and lipolysis directly via the brain stem [18,19,20]. This DMH-mediated sympathetic pathway is regulated by Npy release from Agrp neurons into the DMH and is thus potentially affected by the genetic deletion of Trsp. Therefore, the sympathetic pathway may be involved in the process through which Agrp neurons lacking Trsp promote energy expenditure.
Past evidence suggests that selenoproteins play an important role in supporting leptin signaling in the hypothalamus [3]. For example, the endoplasmic reticulum (ER)-resident selenoprotein M (SELENOM) was found to promote intracellular leptin receptor signaling by upregulating the thioredoxin system and protecting against ER stress [13], a known causative factor in diet-induced leptin resistance [21]. Leptin resistance primarily affects the Arc. While the pathology of leptin resistance is not completely known, there is evidence that Agrp neurons develop leptin resistance prior to other cell types, which may serve as an ‘initiating’ event [22]. We therefore expected that Trsp ablation would make Agrp neurons more vulnerable to developing leptin resistance. We observed the opposite in female TrspAgrpKO mice fed an HFD, however, as the hypothalamus maintained leptin responsivity as a whole and the leptin response in the Arc remained robust. At the surface, it would appear that the loss of the Trsp gene prevents Agrp neurons from developing HFD-induced leptin resistance.
The main driver of diet-induced leptin resistance is thought to be hyperleptinemia secondary to excess weight gain [23]. Therefore, since female TrspAgrpKO mice remained underweight compared to controls throughout HFD administration, they may not have experienced hyperleptinemia comparable to controls throughout the duration of the HFD regimen. Serum leptin levels of female TrspAgrpKO mice were similar to those of female controls, however, despite their lean body composition and heightened leptin sensitivity. One possible explanation for this paradoxical finding is that Agrp neurons in female TrspAgrpKO mice develop some level of leptin resistance initially but are replaced by leptin-responsive adult-born neurons [24]. Whereas ablation of Agrp neurons in adult mice causes severe anorexia and rapid starvation [25], genetically induced progressive degeneration of Agrp neurons results in mice that are viable and slightly underweight despite losing ~85% of Agrp neurons by adulthood [26]. Interestingly, according to this report by Xu et al., progressive Agrp neuron ablation caused a decrease in adiposity in female mice, but not males, similar to the results of our study on TrspAgrpKO mice. It was eventually uncovered that progressive degeneration of Agrp neurons induces a compensatory mechanism of neurogenesis that includes adult-born Agrp neurons that are responsive to leptin [24]. Past research has shown that global Trsp deletion is embryonic lethal [27] and whole-brain neuron-specific knockout of Trsp leads to neurodegeneration and seizures [28]. Therefore, it is plausible that the oxidative stress caused by ablating selenoproteins in Agrp neurons may cause a progressive degeneration that induces compensatory neurogenesis similar to that observed by Xu and colleagues [26]. It is important to note, however, that these studies were performed on mice fed a standard diet rather than an HFD, as used in our current study. Interestingly, Pomc protein levels were significantly increased in female TrspAgrpKO mice in response to leptin, which may indicate a shift towards greater reliance on Pomc neurons. Whether that is the case and whether those Pomc neurons are new adult-born cells produced in response to Agrp neuron degeneration remains to be investigated.
From the current data, it is not possible to deduce whether the ability of Agrp neurons to avoid leptin resistance drives the lean phenotype of female TrspAgrpKO mice or if the adiposity of female TrspAgrpKO mice simply does not reach a level necessary to cause leptin resistance in the first place in the time frame used in our study. In the case of the latter scenario, the implication would be that some other factor is driving the lean phenotype of female TrspAgrpKO mice. As mentioned above, this could occur in the form of upregulated BAT thermogenesis. Either scenario implies that Trsp-lacking Agrp neurons are generally less active than Agrp neurons in control mice as Agrp neurons exert an inhibitory influence on both processes. Indeed, the firing rate of Agrp neurons decreases in response to exogenous reactive oxygen species (ROS) application [29]. Conversely, the anorexigenic Pomc neurons can be activated by ROS [30], suggesting that an oxidative Arc environment promotes a shift towards a negative energy balance. The occurrence of an oxidative suppression of Agrp neuron activity resulting from Trsp deletion would reconcile our results with previous reports.
At first glance, our findings may appear to conflict with previous studies that have reported obesogenic phenotypes resulting from models of hypothalamic selenoprotein disruption. For example, broad hypothalamic silencing of selenoprotein synthesis via RIP-Cre-mediated Trsp deletion was shown by Yagishita et al. [8] to induce oxidative stress in the hypothalamus and result in an increased susceptibility to DIO accompanied by leptin resistance, insulin resistance, and other metabolic disturbances. It is important to note, however, that the RIP-Cre-driven mouse model used in this study did not appear to affect Agrp neurons specifically, which was the target cell population of the current study. Moreover, the finding that Agrp-specific Trsp deletion confers protection against DIO is not surprising, as we have previously reported that SclyAgrpKO mice are protected against DIO and leptin resistance [10]. The loss of Sclyimpairs the process of synthesizing selenocysteine residues for de facto selenoprotein synthesis, and global Scly knockout reduces selenoprotein expression in multiple tissues, including the hypothalamus [31], in addition to producing an obesogenic phenotype [32,33]. We found that Agrp neuron-specific knockout of Scly resulted in a lean phenotype similar to, but milder than, what we have observed with the TrspAgrpKO mice. While the loss of Scly might result in a reduction in selenoprotein expression, Trsp deletion prevents the synthesis of selenoproteins and, presumably, causes even greater vulnerability to oxidative stress. Thus, comparing these two mouse models reveals a potential correlation between the severity of antioxidant incapacitation in Agrp neurons and the extent to which the animal is protected from DIO. It is important to note that there is evidence that alternative amino acids, such as cysteine, can become incorporated rather than selenocysteine [34,35,36,37]. Such a phenomenon might result in non-selenium-containing selenoproteins with diminished functional efficacy. The main difference between the metabolic outcome of these genetic models is that, while both sexes were equally affected by Scly deletion in Agrp neurons, only female TrspAgrpKO mice were protected from DIO and leptin resistance, whereas any differences between male TrspAgrpKO and control mice were barely detectable.
Studies in mice involving selenium and selenoproteins have oftentimes revealed sex differences [33,38,39,40]. To our knowledge, our study is the first to report sex differences in selenoprotein action in the hypothalamus. Although sexual dimorphism within the hypothalamic–pituitary axis has been reported [41], the only potential changes in pituitary-secreted hormones in female TrspAgrpKO mice we observed was a decrease in FSH. There are a few studies on hypothalamic physiology involving neurogenesis that might provide clues about the sex differences observed in TrspAgrpKO mice. A study by Lee et al. found that an HFD activates neurogenesis in the median eminence (ME) of the hypothalamus of female but not male mice [42]. The researchers found that irradiating the ME, thereby inhibiting neurogenesis, reduced DIO in female mice. This suggests that neurogenic processes mediate DIO in female but not male mice. Therefore, if adult-born Agrp neurons comprise an essential component of this mechanism in female mice, then a lack of selenoprotein action may impair their integration into the local homeostatic circuitry. Interestingly, separate work by Bless and colleagues demonstrated that HFD-induced neurogenesis of leptin-responsive neurons is negatively regulated by estradiol [43] and that an HFD leads to estrogen receptor α (ERα)-positive adult-born neurons [44]. It has also been reported that while Agrp neurons are devoid of ERα expression [45], Pomc neurons express ERα [46]. Therefore, if ERα-positive Pomc neurons are able to exert more homeostatic influence as a result of Agrp neuron degeneration, this may serve to limit neurogenesis-mediated DIO in female mice.
Another possible explanation for the observed sex differences is that the localization of Agrp neurons may contribute to the sex differences in TrspAgrpKO mice. One unique quality of Agrp neurons is that a significant portion of them seem to be positioned outside the blood–brain barrier [22]. Moreover, this sub-population seems particularly susceptible to insult and may have a high turnover rate fueled by adult neurogenesis [47]. As mentioned previously, Agrp neurons may develop leptin resistance before other neuronal cell types, and it has been suggested that those lying outside the blood–brain barrier are the first to become desensitized to leptin [22]. If such an event is necessary for the development of leptin resistance, then the ability of female TrspAgrpKO mice fed an HFD to maintain leptin sensitivity could be due to these particular Agrp neurons dying or failing to be replaced via neurogenesis before leptin resistance fully develops. It is not clear whether there are any sex differences in Agrp neurons that reside outside the blood–brain barrier. Thus, further investigation of this unique sub-population may provide insight into the origins of the sex differences seen in TrspAgrpKO mice. Finally, it is also possible that sexual dimorphism beyond the Arc itself within neural circuitry downstream of Agrp neuron activity may play a role in the sex-specific results obtained from TrspAgrpKO mice. Indeed, male and female mice have been found to demonstrate divergence in the sympathetic innervation of adipose tissue [48]. Future studies should unveil the molecular factors and brain circuitry involved.
The results described herein demonstrate the essential nature of selenoproteins in hypothalamic function and energy homeostasis. Remarkably, conditional ablation of selenoprotein synthesis through Trsp gene knockout within a small neural population resulted in substantial changes in the ability of mice to gain excess weight while fed an HFD. The sexual dimorphism displayed by TrspAgrpKO mice may have implications for the apparent sex differences in lipid metabolism that have been observed in humans, particularly with regard to sympathetic activation of adipose tissue and thermogenesis [49,50]. We believe our findings provide novel insight into the interaction between selenium biology and energy homeostasis. Further investigation of hypothalamic selenoproteins may help identify molecular targets that can be leveraged to develop effective therapeutic treatments for obesity and other metabolic diseases.

4. Materials and Methods

4.1. Animals

TrspAgrpKO mice were generated by cross-breeding Agrptm1(Cre)Lowl/J mice [51] (purchased from The Jackson Laboratory, Bar Harbor, ME, USA) with C57/BL6J mice containing loxP sites flanking the gene for selenocysteine tRNA[Ser]Sec, designated Trsp [52]. Age-matched Agrptm1(Cre)Lowl/J mice, referred to as Agrp-Cre mice, were used as controls. Mice were allowed ad libitum food and water access and maintained on a 12 h light/dark cycle. All experiments and procedures were conducted with approval from the University of Hawaii’s Institutional Animal Care and Use Committee (IACUC), protocol: APN 16-2375, last approved 22 September 2021.

4.2. Experimental Design

Mice were fed a high-fat diet containing 45% kcal fat and 4.7 kcal/g (Research Diets, New Brunswick, NJ, USA; D12451) beginning at 4 weeks of age. This diet contains ~0.2 ppm of sodium selenite (Mineral Mix S10026). Past studies using this diet resulted in serum total selenium content levels around 0.4 µg/gm measured via inductively coupled plasma-mass spectrometry [32]. Body weight was measured every 2 weeks and measured at 10:00 a.m. Mice were placed in metabolic cages for feeding behavior and respiratory metabolic assessment at 16 weeks of age. At 18 weeks of age, a glucose tolerance test was performed on each mouse, and body weight monitoring continued until mice were sacrificed at age 24 weeks following leptin challenge. Mice were anesthetized either by CO2 asphyxiation for fresh tissue harvest or via transcardial perfusion with 4% paraformaldehyde following intraperitoneal injection of tribromoethanol for fixed tissue collection.

4.3. Metabolic Chambers

Feeding and drinking behavior, physical activity, and respiratory metabolism were monitored using the PanLab OxyletProTM System (Harvard Apparatus, Barcelona, Spain) as previously described [10]. Mice were acclimated to the metabolic chambers for 24 h prior to 48 h of data collection. Oxygen and carbon dioxide concentrations were measured for 7 min periods every 35 min and used to calculate oxygen consumption (VO2) and carbon dioxide production (VCO2). Data were collected and analyzed using the Panlab METABOLISM software (Vídeňská, Prague, Czech Republic). Energy expenditure (EE) was calculated via indirect calorimetry using the following equation:
EE = (3.815 + (1.232 × RQ)) × VO2 × 1.44
where RQ (Respiratory quotient) is VCO2/VO2.

4.4. Glucose Tolerance Test

Mice were fasted overnight for 16 h. At 10:00 a.m. the next day, blood was accessed via tail vein puncture to measure baseline glycemia. Mice were administered glucose (Sigma; 1 g/kg body weight in sterile phosphate-buffered saline) via intraperitoneal injection. Glycemia was then measured at timepoints of 30 min, 1 h, 2 h, and 3 h post-injection using strips inserted into a glucometer (OneTouch Ultra, LifeScan, Milpitas, CA, USA).

4.5. Leptin Challenge and Tissue Collection

On the day of sacrifice, mice were subjected to a leptin challenge. Mice were fasted overnight for 16 h the night before and injected intraperitoneally with leptin (1 mg/kg body weight; R & D Systems, Minneapolis, MN, USA; 498-OB) or sterilized phosphate-buffered saline as a vehicle control. Mice were sacrificed exactly 1 h post-injection. Tissue was either fixed via transcardial perfusion with 4% paraformaldehyde for immunohistochemical analysis or fresh-frozen in liquid nitrogen to be used for Western blots. Prior to perfusion, mice were euthanized with tribromoethanol (1%, 0.1 mL/g body weight), after which blood was collected via cardiac puncture before perfusion with phosphate buffer, followed by 4% paraformaldehyde in phosphate buffer. Brains were collected and stored overnight in 4% paraformaldehyde for overnight fixation, after which they were dehydrated with daily increased sucrose concentrations. Brains were cut into 40 µm coronal sections using a cryostat and stored in floating fashion in a cryoprotective solution (50% 0.1 M phosphate buffer, 25% glycerol, 25% ethylene glycol). BAT was collected and fixed in 4% paraformaldehyde for 1 week, then paraffin-embedded and cut into 5 µm sections. For collection of fresh tissue, mice were euthanized via CO2 asphyxiation. Blood was collected via cardiac puncture, and inguinal WAT was removed and weighed on an analytical scale. Brains were placed in 30% sucrose on ice for 1 min, after which the hypothalamus was dissected and immediately frozen in liquid nitrogen.

4.6. Gel Electrophoresis and Western Blotting

Frozen tissue was homogenized with a CryoGrinder kit (OPS Diagnostics, Lebanon, NJ, USA; CG 08-01) as previously described [10]. Protein lysate samples containing 40 µg of protein were separated via electrophoresis using a 4–20% gradient polyacrylamide TGX gel (BIO-RAD, Hercules, CA, USA; 5671094) and then transferred onto a 0.45 µm pore size Immobilon-FL polyvinylidene difluoride membrane (Millipore, Burlington, MA, USA; IPFL00010). Membranes were incubated in PBS-based blocking buffer (LI-COR Biosciences, Lincoln, NE, USA; P/N 927) for 1 h, followed by overnight incubation in primary antibody at 4 °C with slow shaking. Blots were washed using PBS containing 0.01% Tween 20 (PBS-T) and incubated with infrared fluorophore-bound secondary antibodies in the dark, washed again with PBS-T, and analyzed using the infrared scanner Odyssey CLx Imaging System (LI-COR Biosciences).

4.7. Immunohistochemistry and Histology

For the visualization of target proteins, a 3,3′-diaminobenzidine (DAB) kit was used (DAB Substrate Kit; Vector Labs, Burlingame, CA, USA; H-2200) in conjunction with an avidin-biotin-peroxidase complex (Elite ABC Kit; Vector Labs; PK-6100). Endogenous peroxidases were first sequestered with 1% H2O2 in methanol, after which sections were blocked in normal goat serum and incubated overnight at 4 °C in primary antibody. Sections were then probed with the appropriate biotinylated secondary antibodies prior to visualization via DAB-mediated reaction. Sections were finally rinsed with phosphate-buffered saline, mounted on glass slides, and dehydrated with an ethanol gradient followed by xylene and cover-slipped.
To visualize BAT morphology, 5 µm sections were stained with hematoxylin and eosin. For measurement of UCP1 immunoreactivity levels, sections were baked in a 60 °C oven for 30 min, deparaffinized using xylene and ethanol, and then incubated in a 1% H2O2/methanol solution for 30 min. Antigen retrieval was performed using 0.01 M citric acid (pH 6), and sections were blocked with an avidin/biotin blocking kit (Vector Labs; SP-2001), followed by incubation with primary antibody. Sections were then incubated in a biotinylated secondary antibody, followed by DAB-mediated staining and mounting as described above.

4.8. Stereology and Data Quantification

Sections were analyzed at bregma −1.46 mm for analysis of the arcuate nucleus. Analysis was performed using the Stereo Investigator Software (MBF Bioscience, Williston, VT, USA) and an upright microscope (Axioskop2; Zeiss, Oberkochen, Germany). For measurement of phospho-STAT3 optical density, a magnification of 20× was used to capture brightfield images which were then imported into ImageJ software for analysis. For quantification, images were first converted into black-and-white, inverted, and then the mean value per pixel was measured within the arcuate nucleus. The Cell Counter ImageJ plugin was used to count the number of phospho-STAT3-positive cells.
For analysis of BAT sections, the simple random sampling function was utilized in Stereo Investigator to capture 20× images. The FIJI (ImageJ v2) plugin Adiposoft was used to count and measure lipid droplet size. To measure UCP1 optical density, images were converted to black-and-white, inverted, and the mean pixel value for the entire image was measured. Assessment of UCP1 optical density was performed as described above for phospho-STAT3.

4.9. Measurement of Serum Hormone Levels

Circulating levels of leptin and insulin were assessed by analyzing serum samples using ELISA kits: Mouse Leptin ELISA Kit (Crystal Chem, Elk Grove Village, IL, USA; 90030) and STELLUX Chemiluminescent Rodent Insulin ELISA Kit (Alpco, Salem, NH, USA; 80-INSMR-CH01). Pituitary hormone levels were measured in serum samples using the Mouse Pituitary Magnetic Bead Panel Milliplex Assay (EMD Millipore, Burlington, MA, USA; MPTMAG-49K), performed with the Luminex 200 Instrument System.

4.10. Antibodies

The primary antibodies used were: a rabbit anti-phospho-STAT3 (Tyr705) (D3A7) (1:1000; Cell Signaling, Danvers, MA, USA; 9145), a rabbit anti-STAT3 (D1A5) (1:1000; Cell Signaling, Danvers, MA, USA; 8768), a mouse anti-Agrp (1:2000; Alpha Diagnostics, San Antonio, TX, USA; AGRP-11S), a rabbit anti-Pomc (27–52, porcine) (Phoenix Pharmaceuticals, Burlingame, CA, USA; H-029-30), a mouse anti-β-actin (8H10D10) (1:5000; Cell Signaling, Danvers, MA, USA; 3700S), and a rabbit anti-UCP1 (1:500; Abcam, Cambridge, MA, USA; ab10983).

4.11. Statistical Analysis

Statistical tests used sample numbers are indicated within each figure legend. Two-way ANOVA, followed by Tukey’s multiple comparisons test, was used to make comparisons using sex and genotype as factors. For data collected over time, including body weight and metabolic cage data, a repeated measures two-way ANOVA was used with Sidak’s multiple comparisons test. An unpaired t-test was used to compare glucose tolerance test results. The graphical representations of data reflect the exact statistical comparisons made. For data affected by leptin challenge, comparisons were made within each sex and used genotype and leptin treatment as factors. Data were analyzed, and graphs were generated using GraphPad Prism version 7 software. All data are presented as mean ± standard error of the mean. Significance was determined by a p-value of <0.05. Sample sizes represent biological replicates.

Supplementary Materials

The following are available online at https://www.mdpi.com/article/10.3390/ijms222011010/s1.

Author Contributions

Conceptualization, D.J.T., M.W.P. and M.J.B.; Data curation, D.J.T., A.C.H., K.W.H. and S.M.A.R.; Formal analysis, D.J.T., M.W.P., L.A.S., K.J.A. and A.N.H.; Funding acquisition, D.J.T., L.A.S. and M.J.B.; Investigation, D.J.T.; Methodology, D.J.T., M.W.P., L.A.S. and A.C.H.; Project administration, M.J.B.; Resources, B.A.C. and D.L.H.; Supervision, M.W.P. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by The National Institutes of Health, grant numbers R01DK047320 (M.J.B.), F32DK124963 (D.J.T.), R01DK128390 (L.A.S.), U54MD007601, and P30GM114737 that supported both core facilities, and the Hawaii Community Foundation, grant number 20ADVC-102166 (L.A.S.)

Institutional Review Board Statement

The study was conducted according to the guidelines of the Declaration of Helsinki and approved by the Institutional Review Board, the University of Hawaii’s Institutional Animal Care and Use Committee (Protocol: APN 16-2375, last approved: 20 May 2021).

Informed Consent Statement

Not applicable.

Data Availability Statement

The data presented in this study are contained within the main article and Supplementary Materials. Inquiries about data should be directed to the corresponding author.

Acknowledgments

Histological techniques and metabolic experiments were conducted with the help of the Histopathology Core and the Murine Behavior and Metabolic Phenotyping Research Support Facility, respectively, at the John A. Burns School of Medicine (JABSOM), which are supported by Ola HAWAII (NIH grant U54MD007601). Milliplex assays were conducted in the Molecular and Cellular Immunology Core at JABSOM, which is supported in part by NIH grant P30GM114737 from the Centers of Biomedical Research Excellence (COBRE) program of the National Institute of General Medical Sciences, a component of the National Institutes of Health. The authors wish to thank Miyoko Bellinger and Kristen Ewell of the Histopathology Core, as well as Alexandra Gurary of the Molecular and Cellular Immunology Core, for their excellent technical assistance.

Conflicts of Interest

The authors declare no conflict of interest.

Abbreviations

Agrpagouti-related peptide
Arcarcuate nucleus
BATbrown adipose tissue
CRHcorticotropin-releasing hormone
DAB3,3′-diaminobenzidine
ERendoplasmic reticulum
ERαestrogen receptor α
FSHfollicle-stimulating hormone
GABAγ-Aminobutyric acid
GHgrowth hormone
DIOdiet-induced obesity
DMHdorsomedial hypothalamus
HFDhigh-fat diet
MEmedian eminence
Npyneuropeptide y
Pomcpro-opiomelanocortin
RIPrat-insulin-promoter
ROSreactive oxygen species
Sclyselenocysteine lyase
SELENOMselenoprotein M
STAT3signal transducer and activator of transcription 3
TRHthyrotropin-releasing hormone
Trspselenocysteine tRNA[Ser]Sec gene
UCP1uncoupling protein-1
WATwhite adipose tissue

References

  1. Caballero, B. Humans against Obesity: Who Will Win? Adv. Nutr. 2019, 10, S4–S9. [Google Scholar] [CrossRef]
  2. Zagmutt, S.; Mera, P.; Soler-Vazquez, M.C.; Herrero, L.; Serra, D. Targeting AgRP neurons to maintain energy balance: Lessons from animal models. Biochem. Pharmacol. 2018, 155, 224–232. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  3. Gong, T.; Torres, D.J.; Berry, M.J.; Pitts, M.W. Hypothalamic redox balance and leptin signaling—Emerging role of selenoproteins. Free Radic. Biol. Med. 2018, 127, 172–181. [Google Scholar] [CrossRef]
  4. Schomburg, L. Selenium, selenoproteins and the thyroid gland: Interactions in health and disease. Nat Rev. Endocrinol 2011, 8, 160–171. [Google Scholar] [CrossRef]
  5. Youn, H.S.; Lim, H.J.; Choi, Y.J.; Lee, J.Y.; Lee, M.Y.; Ryu, J.H. Selenium suppresses the activation of transcription factor NF-kappa B and IRF3 induced by TLR3 or TLR4 agonists. Int. Immunopharmacol. 2008, 8, 495–501. [Google Scholar] [CrossRef]
  6. Zhang, Y.; Zhou, Y.; Schweizer, U.; Savaskan, N.E.; Hua, D.; Kipnis, J.; Hatfield, D.L.; Gladyshev, V.N. Comparative analysis of selenocysteine machinery and selenoproteome gene expression in mouse brain identifies neurons as key functional sites of selenium in mammals. J. Biol. Chem. 2008, 283, 2427–2438. [Google Scholar] [CrossRef] [Green Version]
  7. Henry, F.E.; Sugino, K.; Tozer, A.; Branco, T.; Sternson, S.M. Cell type-specific transcriptomics of hypothalamic energy-sensing neuron responses to weight-loss. eLife 2015, 4, e09800. [Google Scholar] [CrossRef]
  8. Yagishita, Y.; Uruno, A.; Fukutomi, T.; Saito, R.; Saigusa, D.; Pi, J.; Fukamizu, A.; Sugiyama, F.; Takahashi, S.; Yamamoto, M. Nrf2 Improves Leptin and Insulin Resistance Provoked by Hypothalamic Oxidative Stress. Cell. Rep. 2017, 18, 2030–2044. [Google Scholar] [CrossRef] [Green Version]
  9. Schriever, S.C.; Zimprich, A.; Pfuhlmann, K.; Baumann, P.; Giesert, F.; Klaus, V.; Kabra, D.G.; Hafen, U.; Romanov, A.; Tschop, M.H.; et al. Alterations in neuronal control of body weight and anxiety behavior by glutathione peroxidase 4 deficiency. Neuroscience 2017, 357, 241–254. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  10. Torres, D.J.; Pitts, M.W.; Hashimoto, A.C.; Berry, M.J. Agrp-Specific Ablation of Scly Protects against Diet-Induced Obesity and Leptin Resistance. Nutrients 2019, 11, 1693. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  11. Deem, J.D.; Faber, C.L.; Morton, G.J. AgRP neurons: Regulators of feeding, energy expenditure, and behavior. FEBS J. 2021. [Google Scholar] [CrossRef] [PubMed]
  12. Cavaliere, G.; Viggiano, E.; Trinchese, G.; De Filippo, C.; Messina, A.; Monda, V.; Valenzano, A.; Cincione, R.I.; Zammit, C.; Cimmino, F.; et al. Long Feeding High-Fat Diet Induces Hypothalamic Oxidative Stress and Inflammation, and Prolonged Hypothalamic AMPK Activation in Rat Animal Model. Front. Physiol. 2018, 9, 818. [Google Scholar] [CrossRef]
  13. Gong, T.; Hashimoto, A.C.; Sasuclark, A.R.; Khadka, V.S.; Gurary, A.; Pitts, M.W. Selenoprotein M Promotes Hypothalamic Leptin Signaling and Thioredoxin Antioxidant Activity. Antioxid. Redox. Signal. 2019, 35, 775–787. [Google Scholar] [CrossRef]
  14. Pitts, M.W.; Reeves, M.A.; Hashimoto, A.C.; Ogawa, A.; Kremer, P.; Seale, L.A.; Berry, M.J. Deletion of selenoprotein M leads to obesity without cognitive deficits. J. Biol. Chem. 2013, 288, 26121–26134. [Google Scholar] [CrossRef] [Green Version]
  15. Phillips, K.J. Beige Fat, Adaptive Thermogenesis, and Its Regulation by Exercise and Thyroid Hormone. Biology 2019, 8, 57. [Google Scholar] [CrossRef] [Green Version]
  16. Orthofer, M.; Valsesia, A.; Magi, R.; Wang, Q.P.; Kaczanowska, J.; Kozieradzki, I.; Leopoldi, A.; Cikes, D.; Zopf, L.M.; Tretiakov, E.O.; et al. Identification of ALK in Thinness. Cell 2020, 181, 1246–1262.e22. [Google Scholar] [CrossRef] [PubMed]
  17. Liu, P.; Ji, Y.; Yuen, T.; Rendina-Ruedy, E.; DeMambro, V.E.; Dhawan, S.; Abu-Amer, W.; Izadmehr, S.; Zhou, B.; Shin, A.C.; et al. Blocking FSH induces thermogenic adipose tissue and reduces body fat. Nature 2017, 546, 107–112. [Google Scholar] [CrossRef]
  18. Oldfield, B.J.; Giles, M.E.; Watson, A.; Anderson, C.; Colvill, L.M.; McKinley, M.J. The neurochemical characterisation of hypothalamic pathways projecting polysynaptically to brown adipose tissue in the rat. Neuroscience 2002, 110, 515–526. [Google Scholar] [CrossRef]
  19. Bamshad, M.; Song, C.K.; Bartness, T.J. CNS origins of the sympathetic nervous system outflow to brown adipose tissue. Am. J. Physiol. 1999, 276, R1569–R1578. [Google Scholar] [CrossRef]
  20. Zaretskaia, M.V.; Zaretsky, D.V.; Shekhar, A.; DiMicco, J.A. Chemical stimulation of the dorsomedial hypothalamus evokes non-shivering thermogenesis in anesthetized rats. Brain Res. 2002, 928, 113–125. [Google Scholar] [CrossRef]
  21. Ye, Z.; Liu, G.; Guo, J.; Su, Z. Hypothalamic endoplasmic reticulum stress as a key mediator of obesity-induced leptin resistance. Obes. Rev. 2018, 19, 770–785. [Google Scholar] [CrossRef]
  22. Olofsson, L.E.; Unger, E.K.; Cheung, C.C.; Xu, A.W. Modulation of AgRP-neuronal function by SOCS3 as an initiating event in diet-induced hypothalamic leptin resistance. Proc. Natl Acad. Sci. USA 2013, 110, E697–E706. [Google Scholar] [CrossRef] [Green Version]
  23. Friedman, J.M. Leptin and the endocrine control of energy balance. Nat. Metab. 2019, 1, 754–764. [Google Scholar] [CrossRef] [PubMed]
  24. Pierce, A.A.; Xu, A.W. De novo neurogenesis in adult hypothalamus as a compensatory mechanism to regulate energy balance. J. Neurosci. 2010, 30, 723–730. [Google Scholar] [CrossRef] [Green Version]
  25. Luquet, S.; Perez, F.A.; Hnasko, T.S.; Palmiter, R.D. NPY/AgRP neurons are essential for feeding in adult mice but can be ablated in neonates. Science 2005, 310, 683–685. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  26. Xu, A.W.; Kaelin, C.B.; Morton, G.J.; Ogimoto, K.; Stanhope, K.; Graham, J.; Baskin, D.G.; Havel, P.; Schwartz, M.W.; Barsh, G.S. Effects of hypothalamic neurodegeneration on energy balance. PLoS Biol. 2005, 3, 415. [Google Scholar] [CrossRef] [PubMed]
  27. Bosl, M.R.; Takaku, K.; Oshima, M.; Nishimura, S.; Taketo, M.M. Early embryonic lethality caused by targeted disruption of the mouse selenocysteine tRNA gene (Trsp). Proc. Natl Acad. Sci. USA 1997, 94, 5531–5534. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  28. Wirth, E.K.; Conrad, M.; Winterer, J.; Wozny, C.; Carlson, B.A.; Roth, S.; Schmitz, D.; Bornkamm, G.W.; Coppola, V.; Tessarollo, L.; et al. Neuronal selenoprotein expression is required for interneuron development and prevents seizures and neurodegeneration. FASEB J. 2010, 24, 844–852. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  29. Diano, S.; Liu, Z.W.; Jeong, J.K.; Dietrich, M.O.; Ruan, H.B.; Kim, E.; Suyama, S.; Kelly, K.; Gyengesi, E.; Arbiser, J.L.; et al. Peroxisome proliferation-associated control of reactive oxygen species sets melanocortin tone and feeding in diet-induced obesity. Nat. Med. 2011, 17, 1121–1127. [Google Scholar] [CrossRef] [Green Version]
  30. Kuo, D.Y.; Chen, P.N.; Yang, S.F.; Chu, S.C.; Chen, C.H.; Kuo, M.H.; Yu, C.H.; Hsieh, Y.S. Role of reactive oxygen species-related enzymes in neuropeptide y and proopiomelanocortin-mediated appetite control: A study using atypical protein kinase C knockdown. Antioxid. Redox Signal. 2011, 15, 2147–2159. [Google Scholar] [CrossRef] [PubMed]
  31. Ogawa-Wong, A.N.; Hashimoto, A.C.; Ha, H.; Pitts, M.W.; Seale, L.A.; Berry, M.J. Sexual Dimorphism in the Selenocysteine Lyase Knockout Mouse. Nutrients 2018, 10, 159. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  32. Seale, L.A.; Gilman, C.L.; Hashimoto, A.C.; Ogawa-Wong, A.N.; Berry, M.J. Diet-induced obesity in the selenocysteine lyase knockout mouse. Antioxid Redox Signal. 2015, 23, 761–774. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  33. Seale, L.A.; Hashimoto, A.C.; Kurokawa, S.; Gilman, C.L.; Seyedali, A.; Bellinger, F.P.; Raman, A.V.; Berry, M.J. Disruption of the selenocysteine lyase-mediated selenium recycling pathway leads to metabolic syndrome in mice. Mol. Cell. Biol. 2012, 32, 4141–4154. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  34. Romanov, G.A.; Sukhoverov, V.S. Arginine CGA codons as a source of nonsense mutations: A possible role in multivariant gene expression, control of mRNA quality, and aging. Mol. Genet. Genom. 2017, 292, 1013–1026. [Google Scholar] [CrossRef]
  35. Lu, J.; Zhong, L.; Lonn, M.E.; Burk, R.F.; Hill, K.E.; Holmgren, A. Penultimate selenocysteine residue replaced by cysteine in thioredoxin reductase from selenium-deficient rat liver. FASEB J. 2009, 23, 2394–2402. [Google Scholar] [CrossRef] [Green Version]
  36. Tobe, R.; Naranjo-Suarez, S.; Everley, R.A.; Carlson, B.A.; Turanov, A.A.; Tsuji, P.A.; Yoo, M.H.; Gygi, S.P.; Gladyshev, V.N.; Hatfield, D.L. High error rates in selenocysteine insertion in mammalian cells treated with the antibiotic doxycycline, chloramphenicol, or geneticin. J. Biol. Chem. 2013, 288, 14709–14715. [Google Scholar] [CrossRef] [Green Version]
  37. Xu, X.M.; Turanov, A.A.; Carlson, B.A.; Yoo, M.H.; Everley, R.A.; Nandakumar, R.; Sorokina, I.; Gygi, S.P.; Gladyshev, V.N.; Hatfield, D.L. Targeted insertion of cysteine by decoding UGA codons with mammalian selenocysteine machinery. Proc. Natl Acad. Sci. USA 2010, 107, 21430–21434. [Google Scholar] [CrossRef] [Green Version]
  38. Pitts, M.W.; Kremer, P.M.; Hashimoto, A.C.; Torres, D.J.; Byrns, C.N.; Williams, C.S.; Berry, M.J. Competition between the Brain and Testes under Selenium-Compromised Conditions: Insight into Sex Differences in Selenium Metabolism and Risk of Neurodevelopmental Disease. J. Neurosci. 2015, 35, 15326–15338. [Google Scholar] [CrossRef] [Green Version]
  39. Kremer, P.M.; Torres, D.J.; Hashimoto, A.C.; Berry, M.J. Sex-Specific Metabolic Impairments in a Mouse Model of Disrupted Selenium Utilization. Front. Nutr. 2021, 8, 682700. [Google Scholar] [CrossRef]
  40. Seale, L.A.; Ogawa-Wong, A.N.; Berry, M.J. Sexual Dimorphism in Selenium Metabolism and Selenoproteins. Free Radic. Biol. Med. 2018, 127, 198–205. [Google Scholar] [CrossRef]
  41. Oyola, M.G.; Handa, R.J. Hypothalamic-pituitary-adrenal and hypothalamic-pituitary-gonadal axes: Sex differences in regulation of stress responsivity. Stress 2017, 20, 476–494. [Google Scholar] [CrossRef] [PubMed]
  42. Lee, D.A.; Yoo, S.; Pak, T.; Salvatierra, J.; Velarde, E.; Aja, S.; Blackshaw, S. Dietary and sex-specific factors regulate hypothalamic neurogenesis in young adult mice. Front. Neurosci. 2014, 8, 157. [Google Scholar] [CrossRef] [Green Version]
  43. Bless, E.P.; Reddy, T.; Acharya, K.D.; Beltz, B.S.; Tetel, M.J. Oestradiol and diet modulate energy homeostasis and hypothalamic neurogenesis in the adult female mouse. J. Neuroendocrinol. 2014, 26, 805–816. [Google Scholar] [CrossRef] [Green Version]
  44. Bless, E.P.; Yang, J.; Acharya, K.D.; Nettles, S.A.; Vassoler, F.M.; Byrnes, E.M.; Tetel, M.J. Adult Neurogenesis in the Female Mouse Hypothalamus: Estradiol and High-Fat Diet Alter the Generation of Newborn Neurons Expressing Estrogen Receptor alpha. eNeuro 2016, 3. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  45. Olofsson, L.E.; Pierce, A.A.; Xu, A.W. Functional requirement of AgRP and NPY neurons in ovarian cycle-dependent regulation of food intake. Proc. Natl Acad. Sci. USA 2009, 106, 15932–15937. [Google Scholar] [CrossRef] [Green Version]
  46. De Souza, F.S.; Nasif, S.; Lopez-Leal, R.; Levi, D.H.; Low, M.J.; Rubinsten, M. The estrogen receptor alpha colocalizes with proopiomelanocortin in hypothalamic neurons and binds to a conserved motif present in the neuron-specific enhancer nPE2. Eur. J. Pharmacol. 2011, 660, 181–187. [Google Scholar] [CrossRef] [Green Version]
  47. Yulyaningsih, E.; Rudenko, I.A.; Valdearcos, M.; Dahlen, E.; Vagena, E.; Chan, A.; Alvarez-Buylla, A.; Vaisse, C.; Koliwad, S.K.; Xu, A.W. Acute Lesioning and Rapid Repair of Hypothalamic Neurons outside the Blood-Brain Barrier. Cell. Rep. 2017, 19, 2257–2271. [Google Scholar] [CrossRef] [Green Version]
  48. Kim, S.N.; Jung, Y.S.; Kwon, H.J.; Seong, J.K.; Granneman, J.G.; Lee, Y.H. Sex differences in sympathetic innervation and browning of white adipose tissue of mice. Biol. Sex Differ. 2016, 7, 67. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  49. Toth, M.J.; Gardner, A.W.; Arciero, P.J.; Calles-Escandon, J.; Poehlman, E.T. Gender differences in fat oxidation and sympathetic nervous system activity at rest and during submaximal exercise in older individuals. Clin. Sci. 1998, 95, 59–66. [Google Scholar] [CrossRef]
  50. Herz, C.T.; Kulterer, O.C.; Prager, M.; Marculescu, R.; Langer, F.B.; Prager, G.; Kautzky-Willer, A.; Haug, A.R.; Kiefer, F.W. Sex differences in brown adipose tissue activity and cold-induced thermogenesis. Mol. Cell. Endocrinol. 2021, 534, 111365. [Google Scholar] [CrossRef]
  51. Tong, Q.; Ye, C.P.; Jones, J.E.; Elmquist, J.K.; Lowell, B.B. Synaptic release of GABA by AgRP neurons is required for normal regulation of energy balance. Nat. Neurosci. 2008, 11, 998–1000. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  52. Kumaraswamy, E.; Carlson, B.A.; Morgan, F.; Miyoshi, K.; Robinson, G.W.; Su, D.; Wang, S.; Southon, E.; Tessarollo, L.; Lee, B.J.; et al. Selective removal of the selenocysteine tRNA [Ser]Sec gene (Trsp) in mouse mammary epithelium. Mol. Cell. Biol. 2003, 23, 1477–1488. [Google Scholar] [CrossRef] [PubMed] [Green Version]
Ijms 22 11010 g001 550
Figure 1. Metabolic profile of TrspAgrpKO mice of both sexes raised on a high-fat diet. Female TrspAgrpKO mice (a) gained less weight while on a high-fat diet compared to Agrp-Cre controls; however, there was no effect of TrspAgrpKO in the body weight of male mice (b) (Sidak’s multiple comparisons test following repeated measures: **** p < 0.0001). Inguinal white adipose tissue (WAT) deposits weighed less in female TrspAgrpKO mice (c) and were unchanged in male TrspAgrpKO mice (Tukey’s multiple comparisons test following two-way analysis of variance: *** p = 0.0008). Glucose tolerance was elevated in female TrspAgrpKO mice (d,e) compared to controls (unpaired t-test comparing area under the curve: * p = 0.03) and remained unaffected in males (f). Feeding behavior (g,h) was not significantly changed in TrspAgrpKO mice of either sex during 48 h recordings. Samples sizes are displayed in the graphs. All values shown are mean ± standard error of the mean.
Figure 1. Metabolic profile of TrspAgrpKO mice of both sexes raised on a high-fat diet. Female TrspAgrpKO mice (a) gained less weight while on a high-fat diet compared to Agrp-Cre controls; however, there was no effect of TrspAgrpKO in the body weight of male mice (b) (Sidak’s multiple comparisons test following repeated measures: **** p < 0.0001). Inguinal white adipose tissue (WAT) deposits weighed less in female TrspAgrpKO mice (c) and were unchanged in male TrspAgrpKO mice (Tukey’s multiple comparisons test following two-way analysis of variance: *** p = 0.0008). Glucose tolerance was elevated in female TrspAgrpKO mice (d,e) compared to controls (unpaired t-test comparing area under the curve: * p = 0.03) and remained unaffected in males (f). Feeding behavior (g,h) was not significantly changed in TrspAgrpKO mice of either sex during 48 h recordings. Samples sizes are displayed in the graphs. All values shown are mean ± standard error of the mean.
Ijms 22 11010 g001
Ijms 22 11010 g002 550
Figure 2. Respiratory metabolism of female TrspAgrpKO mice raised on a high-fat diet. Female TrspAgrpKO mice displayed elevated oxygen consumption (VO2, volume of oxygen) (a,b), carbon dioxide production (VCO2, volume of carbon dioxide) (c,d), and energy expenditure (e,f) compared to Agrp-Cre control mice. Two-way repeated-measures analysis of variance was used to compare the area under the curve during both light and dark cycles. Sidak’s multiple comparisons test: * p < 0.05, ** p < 0.01. Samples sizes are displayed in the graphs. All values shown are mean ± standard error of the mean.
Figure 2. Respiratory metabolism of female TrspAgrpKO mice raised on a high-fat diet. Female TrspAgrpKO mice displayed elevated oxygen consumption (VO2, volume of oxygen) (a,b), carbon dioxide production (VCO2, volume of carbon dioxide) (c,d), and energy expenditure (e,f) compared to Agrp-Cre control mice. Two-way repeated-measures analysis of variance was used to compare the area under the curve during both light and dark cycles. Sidak’s multiple comparisons test: * p < 0.05, ** p < 0.01. Samples sizes are displayed in the graphs. All values shown are mean ± standard error of the mean.
Ijms 22 11010 g002
Ijms 22 11010 g003 550
Figure 3. Brown adipose tissue morphology of TrspAgrpKO mice of both sexes raised on a high-fat diet. (a) Sample images of hematoxylin and eosin-stained brown adipose tissue sections from female and male TrspAgrpKO and Agrp-Cre control mice. (b) The size of lipid droplets measured sections from female TrspAgrpKO mice was more frequently present in smaller sizes compared to female Agrp-Cre control mice (two-way repeated-measures analysis of variance followed by Sidak’s multiple comparisons: **** p < 0.0001). No changes were seen in male mice. (c) Average lipid fraction, which is the percentage of the section occupied by lipid droplet, was significantly lower in female TrspAgrpKO mice compared to Agrp-Cre control mice (d) (two-way analysis of variance, followed by Tukey’s multiple comparisons test: ** p = 0.007). Samples sizes are displayed in the graphs. All values shown are mean ± standard error of the mean.
Figure 3. Brown adipose tissue morphology of TrspAgrpKO mice of both sexes raised on a high-fat diet. (a) Sample images of hematoxylin and eosin-stained brown adipose tissue sections from female and male TrspAgrpKO and Agrp-Cre control mice. (b) The size of lipid droplets measured sections from female TrspAgrpKO mice was more frequently present in smaller sizes compared to female Agrp-Cre control mice (two-way repeated-measures analysis of variance followed by Sidak’s multiple comparisons: **** p < 0.0001). No changes were seen in male mice. (c) Average lipid fraction, which is the percentage of the section occupied by lipid droplet, was significantly lower in female TrspAgrpKO mice compared to Agrp-Cre control mice (d) (two-way analysis of variance, followed by Tukey’s multiple comparisons test: ** p = 0.007). Samples sizes are displayed in the graphs. All values shown are mean ± standard error of the mean.
Ijms 22 11010 g003
Ijms 22 11010 g004 550
Figure 4. Western blot analysis of broad hypothalamic leptin signaling in TrspAgrpKO mice of both sexes raised on a high-fat diet. Leptin (OB) injection did not elicit a significant increase in phosphorylated STAT3 (pSTAT3) protein levels in female Agrp-Cre control mice compared to vehicle (VEH)-injected Agrp-Cre mice (a,b). Female TrspAgrpKO mice, however, displayed an increase in pSTAT3 levels in response to leptin injection (two-way analysis of variance, followed by Tukey’s multiple comparisons test: * p = 0.04). Leptin injection failed to significantly elevate pSTAT3 protein levels in the hypothalamus of either Agrp-Cre or TrspAgrpKO male mice (c,d). Samples sizes are displayed in the graphs. All values shown are mean ± standard error of the mean.
Figure 4. Western blot analysis of broad hypothalamic leptin signaling in TrspAgrpKO mice of both sexes raised on a high-fat diet. Leptin (OB) injection did not elicit a significant increase in phosphorylated STAT3 (pSTAT3) protein levels in female Agrp-Cre control mice compared to vehicle (VEH)-injected Agrp-Cre mice (a,b). Female TrspAgrpKO mice, however, displayed an increase in pSTAT3 levels in response to leptin injection (two-way analysis of variance, followed by Tukey’s multiple comparisons test: * p = 0.04). Leptin injection failed to significantly elevate pSTAT3 protein levels in the hypothalamus of either Agrp-Cre or TrspAgrpKO male mice (c,d). Samples sizes are displayed in the graphs. All values shown are mean ± standard error of the mean.
Ijms 22 11010 g004
Ijms 22 11010 g005 550
Figure 5. Leptin signaling in brain sections of TrspAgrpKO mice of both sexes raised on a high-fat diet. Sample images of hypothalamic sections stained for phosphorylated STAT3 (pSTAT3) following in vivo challenge with either vehicle (VEH, saline) or leptin (OB) (a). Images are of the medio-basal hypothalamic area containing the arcuate nucleus and were captured at 20× magnification. Optical density of pSTAT3 immunoreactivity, visualized via 3,3′-diaminobenzidine staining, in the arcuate nucleus of female TrspAgrpKO mice was significantly increased by leptin challenge, but not in Agrp-Cre control mice (b) (two-way analysis of variance, followed by Tukey’s multiple comparisons test: * p = 0.03). No change in the number of pSTAT3-positive cells in female TrspAgrpKO mice was detected (c), however. (d) Neither genotype nor leptin administration affected pSTAT3 optical density (e) or cell count (f) in male mice. Samples sizes are displayed in the graphs. All values shown are mean ± standard error of the mean.
Figure 5. Leptin signaling in brain sections of TrspAgrpKO mice of both sexes raised on a high-fat diet. Sample images of hypothalamic sections stained for phosphorylated STAT3 (pSTAT3) following in vivo challenge with either vehicle (VEH, saline) or leptin (OB) (a). Images are of the medio-basal hypothalamic area containing the arcuate nucleus and were captured at 20× magnification. Optical density of pSTAT3 immunoreactivity, visualized via 3,3′-diaminobenzidine staining, in the arcuate nucleus of female TrspAgrpKO mice was significantly increased by leptin challenge, but not in Agrp-Cre control mice (b) (two-way analysis of variance, followed by Tukey’s multiple comparisons test: * p = 0.03). No change in the number of pSTAT3-positive cells in female TrspAgrpKO mice was detected (c), however. (d) Neither genotype nor leptin administration affected pSTAT3 optical density (e) or cell count (f) in male mice. Samples sizes are displayed in the graphs. All values shown are mean ± standard error of the mean.
Ijms 22 11010 g005
Ijms 22 11010 g006 550
Figure 6. Western blot analysis of broad hypothalamic neuropeptide expression in TrspAgrpKO mice of both sexes raised on a high-fat diet. Female TrspAgrpKO mice displayed no significant changes in expression of agouti-related peptide (Agrp), but pro-opiomelanocortin (Pomc) was significantly elevated in female TrspAgrpKO mice in response to leptin (OB) compared to vehicle (VEH)-injected TrspAgrpKO mice (a–c) (Two-way analysis of variance, followed by Tukey’s multiple comparisons test: * p = 0.04). Male TrspAgrpKO mice showed no significant changes in Agrp or Pomc protein levels as a result of either genotype or leptin injection (d–f). Samples sizes are displayed in the graphs. All values shown are mean ± standard error of the mean.
Figure 6. Western blot analysis of broad hypothalamic neuropeptide expression in TrspAgrpKO mice of both sexes raised on a high-fat diet. Female TrspAgrpKO mice displayed no significant changes in expression of agouti-related peptide (Agrp), but pro-opiomelanocortin (Pomc) was significantly elevated in female TrspAgrpKO mice in response to leptin (OB) compared to vehicle (VEH)-injected TrspAgrpKO mice (a–c) (Two-way analysis of variance, followed by Tukey’s multiple comparisons test: * p = 0.04). Male TrspAgrpKO mice showed no significant changes in Agrp or Pomc protein levels as a result of either genotype or leptin injection (d–f). Samples sizes are displayed in the graphs. All values shown are mean ± standard error of the mean.
Ijms 22 11010 g006
Table
Table 1. Serum expression levels of hormones TrspAgrpKO and Agrp-Cre mice.
Table 1. Serum expression levels of hormones TrspAgrpKO and Agrp-Cre mice.
Hormone Type and NameAgrp-CreTrspAgrpKOp Value
Females:
Metabolic hormones
Leptin (ng/mL)32.78 ± 1.58 (n = 7)31.54 ± 2.18 (n = 9)0.67
Insulin (ng/mL)0.54 ± 0.11 (n = 7)0.32 ± 0.04 (n = 8)0.06
Pituitary hormones
ACTH (pg/mL)20.06 ± 4.69 (n = 7)21.75 ± 4.11 (n = 8)0.79
FSH (ng/mL)1.41 ± 0.54 (n = 6)0.39 ± 0.11 (n = 8)0.05
GH (ng/mL)1.09 ± 0.43 (n = 6)1.97 ± 0.74 (n = 9)0.39
LH (pg/mL)125.65 ± 43.95 (n = 7)248.90 ± 76.29 (n = 8)0.20
Prolactin (ng/mL)9.72 ± 2.10 (n = 7)8.36 ± 1.49 (n = 8)0.60
TSH (pg/mL)49.40 ± 5.27 (n = 6)61.57 ± 25.53 (n = 8)0.67
Males:
Metabolic hormones
Leptin (ng/mL)32.58 ± 2.26 (n = 8)28.38 ± 2.15 (n = 9)0.20
Insulin (ng/mL)0.93 ± 0.26 (n = 8)1.30 ± 0.37 (n = 9)0.44
Pituitary hormones
ACTH (pg/mL)17.94 ± 3.46 (n = 8)22.05 ± 5.53 (n = 9)0.55
FSH (ng/mL)3.19 ± 0.67 (n = 8)2.77 ± 0.41 (n = 9)0.59
GH (ng/mL)0.54 ± 0.09 (n = 6)2.14 ± 0.54 (n = 9)0.03
LH (pg/mL)392.17 ± 166.81 (n = 8)653.28 ± 200.41 (n = 9)0.34
Prolactin (ng/mL)1.15 ± 0.33 (n = 8)2.07 ± 0.85 (n = 9)0.35
TSH (pg/mL)173.10 ± 43.22 (n = 8)258.30 ± 53.23 (n = 9)0.24
Boldface indicates significance and italicized text indicates a statistically non-significant trend. Comparisons were made between genotypes of the same sex using unpaired t-tests; n = 6–9 per group. All values shown are mean ± S.E.M. Abbreviations: ACTH, adrenocorticotropic hormone; FH, follicle-stimulating hormone; GH, growth hormone; LH, luteinizing hormone; TSH, thyroid-stimulating hormone.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Torres, D.J.; Pitts, M.W.; Seale, L.A.; Hashimoto, A.C.; An, K.J.; Hanato, A.N.; Hui, K.W.; Remigio, S.M.A.; Carlson, B.A.; Hatfield, D.L.; et al. Female Mice with Selenocysteine tRNA Deletion in Agrp Neurons Maintain Leptin Sensitivity and Resist Weight Gain While on a High-Fat Diet. Int. J. Mol. Sci. 2021, 22, 11010. https://doi.org/10.3390/ijms222011010

AMA Style

Torres DJ, Pitts MW, Seale LA, Hashimoto AC, An KJ, Hanato AN, Hui KW, Remigio SMA, Carlson BA, Hatfield DL, et al. Female Mice with Selenocysteine tRNA Deletion in Agrp Neurons Maintain Leptin Sensitivity and Resist Weight Gain While on a High-Fat Diet. International Journal of Molecular Sciences. 2021; 22(20):11010. https://doi.org/10.3390/ijms222011010

Chicago/Turabian Style

Torres, Daniel J., Matthew W. Pitts, Lucia A. Seale, Ann C. Hashimoto, Katlyn J. An, Ashley N. Hanato, Katherine W. Hui, Stella Maris A. Remigio, Bradley A. Carlson, Dolph L. Hatfield, and et al. 2021. "Female Mice with Selenocysteine tRNA Deletion in Agrp Neurons Maintain Leptin Sensitivity and Resist Weight Gain While on a High-Fat Diet" International Journal of Molecular Sciences 22, no. 20: 11010. https://doi.org/10.3390/ijms222011010

APA Style

Torres, D. J., Pitts, M. W., Seale, L. A., Hashimoto, A. C., An, K. J., Hanato, A. N., Hui, K. W., Remigio, S. M. A., Carlson, B. A., Hatfield, D. L., & Berry, M. J. (2021). Female Mice with Selenocysteine tRNA Deletion in Agrp Neurons Maintain Leptin Sensitivity and Resist Weight Gain While on a High-Fat Diet. International Journal of Molecular Sciences, 22(20), 11010. https://doi.org/10.3390/ijms222011010

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop